Company Profiles

Find premium company profile research reports. Purchase and download high quality report analysis, company reports, and much more

DocStore Search:
Per Page: 152550
  • Action Electronics Company Profile - Aug 21, 2011
    Action Electronics Company Profile - Aug 21, 2011

    $24.95

    Document Overview:
    Action Electronics Co., Ltd. is principally engaged in the manufacture, processing, distribution, maintenance and technology services of electronic products. The Company provides liquid crystal display (LCD) players, LCD televisions, digital photo frames, digital photo albums, digital LCD players, mobile televisions, network video products and other products. The Company also involves in the provision of related technology transfer and consulting services. It distributes its products primarily in Asia, Europe and the Americas.
    View Document
  • Action Pharma AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
    Action Pharma AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    Action Pharma A/S (Action Pharma) is a biotechnology company, based in Denmark. It discovers and develops new drugs and treatment concepts to treat cardiovascular disease and inflammatory diseases, as well as metabolic diseases, such as type-II diabetes and obesity. The product pipeline of the company includes AP1030, an oral anti-diabetic (OAD) for the treatment of type-II diabetes associated with overweight/obesity; and AP214, a modified DMSH-peptide analogue to treat post-surgical kidney injury associated with cardiac surgery. Action Pharma also develops AP1189, an oral anti-inflammatory compound to treat inflammatory diseases, such as inflammatory bowel disease and rheumatoid arthritis. It also offers AP405, which is a modified MSH peptide analogue to treat inflammatory skin diseases such as atopic dermatitis. Action Pharma is headquartered in Arhus, Denmark.
    View Document
  • Action Press Holding AG Company Profile - Sep 07, 2011
    Action Press Holding AG Company Profile - Sep 07, 2011

    $24.95

    Document Overview:
    Action Press Holding AG is a Germany-based holding company engaged in advertising and marketing through its subsidiaries. The Company divides its activities into the two business segments Marketing and Social Research as well as Photo. The activities of Marketing and Social Research are carried out through the Company's majority owned subsidiary infas Institut fuer angewandte Sozialwissenschaften GmbH, which is active in the area of opinion polling, market research and social research for governmental, academic and corporate clients. The Company's wholly owned subsidiary press gmbh & co. kg is active within the Photo segment and operates a licensed digital photographic database, which contains approximately five million images for use by subscribers and clients, covering celebrities, politics, economics and sports. Action Press Holding AG's third subsidiary includes the wholly owned action press beteiligungsgesellschaft mbH.
    View Document
  • Action Products International Company Profile - Dec 15, 2010
    Action Products International Company Profile - Dec 15, 2010

    $24.95

    Document Overview:
    Action Products International, Inc. (Action Products) is a global manufacturer and distributor of brand-focused educational toys and activities within the specialty toy industry. The Company's Toy & Craft business designs, manufactures and markets a portfolio of educational, positive and non-violent brands of toys, crafts, gifts and activity products, to various retailing channels, such as independent toy stores, gift stores, craft and hobby stores, specialty and discount retail chains, museums, zoos, aquariums, theme parks and attractions primarily in the United States and Canada. Its toy and craft operation primarily designs, markets and sells educational toy products under the name Action Toys. Products include wooden toys, action figures, play-sets, activity kits and various other playthings with an emphasis on non-violent, educational and fun topics, such as space, dinosaurs, science and nature.
    View Document
  • Activa Resources AG (NXI) - Oil & Gas - Deals and Alliances Profile
    Activa Resources AG (NXI) - Oil & Gas - Deals and Alliances Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    Activa Resources AG (Activa Resources) is an independent oil and gas company. The company acquires, develops and explores oil and gas properties for production of crude oil and natural gas. Activa's geographic operating areas include Gulf coast, Texas and Louisiana in the U.S. Its core properties/ projects include, Adams Ranch field, OSR Halliday, Gray Waterflood field and Loma field. The company's other projects are CERF, Hidalgo Frio, Hogg-Heaven and Santa Rosa field. Activa also holds drilling rights in Montgomery Wilcox field, Barnett Shale and Fayetteville Shale. The company operates in the US through its wholly owned subsidiary, Activa Resources LLC. It is headquartered in Bad Homburg, Germany.
    View Document
  • Activa Resources AG Company Profile - Aug 16, 2011
    Activa Resources AG Company Profile - Aug 16, 2011

    $24.95

    Document Overview:
    Activa Resources AG is a Germany-based company that is engaged in the discovery, acquisition, development and exploitation of oil and natural gas properties in the United States of America. The Company focuses on producing petroleum and natural gas products and doesn't participate in refining or transportation. It is engaged in a variety of onshore oil and gas projects in the states of Louisiana, Arkansas and Texas in the United States. The Company operates through its wholly owned subsidiary Activa Holding Corp., the United States and its wholly owned Activa Resources LLC in San Antonio, Texas, the United States.
    View Document
  • Activaero GmbH - Medical Equipment - Deals and Alliances Profile
    Activaero GmbH - Medical Equipment - Deals and Alliances Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    Activaero GmbH (Activaero) is a medical device company. The company researches, develops, manufactures, and sells breathing inhalation devices. Its products segments include Flavorestin and Pipeline. Pipeline products include Flavorestin, SCIPE, Alpha-1 Antitrypsin. Activaero offers inhalation devices to the patients suffering from asthma, cystic fibrosis, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and other severe lung diseases. The company develops cutting-edge solutions. It provides services in the areas of aerosol science, clinical development, clinical project management, regulatory, and quality and clinical consulting. The company partners with GRIFOLS, Ablynx, inamed, RPC, UKGM, Forest Laboratories, Inc. and others. Activaero is headquartered in Gemunden, Hessen, Germany.
    View Document
  • Activaero GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
    Activaero GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    Activaero GmbH (Activaero) is a medical device company. The company researches, develops, manufactures, and sells breathing inhalation devices. Its products segments include Flavorestin and Pipeline. Pipeline products include Flavorestin, SCIPE, Alpha-1 Antitrypsin. Activaero offers inhalation devices to the patients suffering from asthma, cystic fibrosis, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and other severe lung diseases. The company develops cutting-edge solutions. It provides services in the areas of aerosol science, clinical development, clinical project management, regulatory, and quality and clinical consulting. The company partners with GRIFOLS, Ablynx, inamed, RPC, UKGM, Forest Laboratories, Inc. and others. Activaero is headquartered in Gemunden, Hessen, Germany. Activaero GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Merger
    View Document
  • Active Alliance Incorporated
    Active Alliance Incorporated

    $39.95

    Document Overview:
    Active Alliance Incorporated. The Company's principal activity is manufacturing electronic devices, specifically assembly of printed circuit boards. Its primary purpose is to engage in the business of dealing in all kinds of articles of commerce, including but not limited to consumer communication, electronic equipment and other goods of similar nature, and any and all equipment, materials, and supplies used or employed in or related to the manufacture of such finished products.
    View Document
  • Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review
    Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    Active Biotech AB (Active Biotech) is a biotechnology company. It undertakes the development and commercialization of pharmaceuticals in the field of autoimmune/inflammatory diseases and cancer. The company's three projects are in pivotal phase, namely, laquinimod; drug for the treatment of multiple sclerosis; TASQ; for the treatment of prostate cancer; and ANYARA; drug used in cancer targeted therapy. Also, laquinimod is in Phase II development for the treatment of Crohn's disease and Lupus. The two orally administered compounds of the company, 57- 57 and RhuDexTM, which are used in the treatment of systemic sclerosis and RA are in clinical development stage. Active Biotech is headquartered in Lund, Sweden. Active Biotech along with Ipsen, its partner for the co development and commercialization of Tasquinimoid, published overall survival data of Tasquinimod Phase II study in chemotherapy-naïve metastatic castrate resistant prostate cancer.
    View Document
  • Active Biotech AB (ACTI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
    Active Biotech AB (ACTI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    Active Biotech AB (Active Biotech) is a biotechnology company. It undertakes the development and commercialization of pharmaceuticals in the field of autoimmune/inflammatory diseases and cancer. The company has five projects in clinical development of which three have been licensed out. Its key products in development include laquinimod, for the treatment of multiple sclerosis; tasquinimod for the treatment of prostate cancer; ANYARA for the treatment of renal cell cancer. Laquinimod is also in Phase II development for the treatment of Crohn's disease and Lupus. The other two orally administered compounds include Paquinimod is a quinoline compound in development for the treatment of systemic sclerosis and RhuDexTM, which is in development for the treatment of rheumatoid arthritis. Active Biotech has licensing agreements with Teva, Ipsen and MediGene AG. Active Biotech is headquartered in Lund, Sweden. Active Biotech’s key business strategy is to progress the clinical development of its lead components. The company recently filed marketing authorization application (MAA) for its lead product candidate laquinimod in Europe and intends to file NDA for the candidate with the FDA following an another clinical study. Active Biotech AB (ACTI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's
    View Document
  • Active Biotech AB Company Profile - Aug 05, 2011
    Active Biotech AB Company Profile - Aug 05, 2011

    $24.95

    Document Overview:
    Active Biotech AB is a Sweden-based company that focuses on pharmaceutical research and development in medical fields in which the immune system plays a central role. The Company's research portfolio primarily includes projects for the development of drugs for the treatment of autoimmune and inflammatory diseases and cancer. As of December 31, 2010, Active Biotech had five projects in clinical phase, two of which are outlicensed. Three of the projects relate to drugs for the treatment of the autoimmune diseases, multiple sclerosis (MS), systemic lupus erythematosus (SLE), Crohn's disease, Systemic Sclerosis and rheumatoid arthritis (RA), and two of the projects focus on drugs for the treatment of cancer, mainly renal cell cancer and prostate cancer. The Company operates through subsidiaries, including Active Forskaren 1 KB, Actinova AB and Active Security Trading AB. During the fiscal year 2010, the subsidiary Active Biotech Research AB was merged with the Company.
    View Document
  • Active Implants Corporation - Medical Equipment - Deals and Alliances Profile
    Active Implants Corporation - Medical Equipment - Deals and Alliances Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    Active Implants Corporation (AIC) is an orthopedic medical device manufacturer. The company develops and commercializes polymer orthopedic implants solutions. Its products include nusurface meniscus implant, tribofit hip system and tribofit instrumentation equipments. The company develops and markets low wear and bone spurting orthopedic implant solutions made of polyurethane materials. AIC’s orthopedic implant solutions are developed using pliable structured materials. AIC’s joint replacement products are developed using polycarbonate urethane (PCU) materials. The company utilizes the biocompatibility and biostability aspects of the PCU materials for developing low wear and bone sparting orthopedic implant solutions. The R&D sector includes designing, production of prototypes, testing, animal trials and validation.The company has offices in Netanya, Israel and Driebergen, the Netherlands. AIC is headquartered in Memphis, Tennessee, the US.
    View Document
Per Page: 152550